Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,501.24
(
0.77%
)
US TECH 100
28,791.60
(
0.00%
)
Dow Jones
50,063.46
(
0.75%
)
Brent Oil
104.83
(
0.62%
)
Bitcoin
80,805.60
(
-0.31%
)
News Focus
News Focus
Post# of 257566
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

HDGabor

Send PM Follow Ignore
Followers 142
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

HDGabor

Re: DewDiligence post# 237594

Tuesday, 03/30/2021 2:02:42 PM

Tuesday, March 30, 2021 2:02:42 PM

Post# of 257566
D-

Advancing Phase 1b/2a trial for WVE-003 (SNP3) program in HD; WVE-003 uses new PN backbone chemistry modifications, which demonstrate improved preclinical pharmacology. Wave expects to initiate dosing in a Phase 1b/2a clinical trial for WVE-003 in 2021.

Best,
G

Disclosure: I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.

Notice: This post is not investment advice, and not a recommendation to neither buy nor hold nor sell.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today